Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/33067
Title: | Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection Fraction | Authors: | Segar, Matthew W. Patel, Ravi B. Patel, Kershaw V. Fudim, Marat DeVore, Adam D. MARTENS, Pieter Hedayati, S. Susan Grodin, Justin L. Tang, W. H. Wilson Pandey, Ambarish |
Issue Date: | 2021 | Publisher: | AMER MEDICAL ASSOC | Source: | JAMA cardiology (Print), 6 (1), p. 68-77 | Abstract: | This secondary cohort study evaluates the associations of visit-to-visit variability in indexes of kidney function and serum electrolytes with the risk of adverse clinical outcomes among patients with chronic, stable heart failure with preserved ejection fraction. Question Is visit-to-visit variability in kidney function and serum electrolyte indexes associated with risk of adverse clinical outcomes among patients with chronic, stable heart failure with preserved ejection fraction? Findings This cohort study of patients with chronic heart failure with preserved ejection fraction suggests that higher visit-to-visit variability in creatinine, blood urea nitrogen, sodium, and potassium levels is significantly associated with a higher risk of adverse clinical outcomes independent of other potential confounders and changes in these parameters. Meaning In heart failure with preserved ejection fraction, visit-to-visit variability in laboratory indexes of kidney function and certain serum electrolytes may identify a higher-risk disease state with worse long-term clinical outcomes. Importance Although kidney dysfunction and abnormalities in serum electrolyte levels are associated with poor clinical outcomes in patients with heart failure with preserved ejection fraction (HFpEF), the association of visit-to-visit variability in such laboratory measures with long-term outcomes is unclear. Objective To evaluate the associations of visit-to-visit variability in indexes of kidney function (creatinine and blood urea nitrogen [BUN] levels) and serum electrolyte (sodium, chloride, and potassium) with the risk of adverse clinical outcomes among patients with chronic, stable HFpEF. Design, Setting, and Participants This cohort analysis used data from the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial. All participants with 3 or more serial laboratory measurements who were event free within the first 4 months of enrollment were included. Data were analyzed from March 1, 2019, to January 31, 2020. Main Outcomes and Measures Adjusted associations between indexes of variability in serum laboratory measurements during the first 4 months of follow-up and risk of the primary composite outcome (a composite of aborted cardiac arrest, hospitalization for heart failure, or cardiovascular death) and all-cause mortality were assessed using Cox proportional hazards regression models. Results Of the 3445 patients enrolled in the TOPCAT trial (mean [SD] age, 68-69 [10] years; 49.7%-51.5% female), 2479 (BUN) to 3195 (potassium) were analyzed, depending on availability of serial measurements. Participants with higher laboratory variability in kidney function parameters were older, had more comorbidities, and had more severe symptoms of HFpEF. Higher visit-to-visit variability in BUN (hazard ratio [HR] per 1-SD higher average successive variability [ASV], 1.21; 95% CI, 1.10-1.33) and creatinine (HR per 1-SD higher ASV, 1.13; 95% CI, 1.04-1.22) were independently associated with a higher risk of the primary composite outcome as well as mortality independent of other baseline confounders, changes in kidney function, changes in medication dosages, and variability in other cardiometabolic parameters (systolic blood pressure and body mass index). The higher risk associated with greater variability in kidney function was consistent across subgroups of patients stratified by the presence of chronic kidney disease (CKD) at baseline (CKD: HR per 1-SD higher ASV, 1.39; 95% CI, 1.16-1.67 and no CKD: HR per 1-SD higher ASV, 1.13; 95% CI, 1.01-1.27), among placebo and spironolactone treatment arms separately (spironolactone arm: 1.30; 95% CI, 1.03-1.65 and placebo arm: HR per 1-SD higher ASV, 1.27; 95% CI, 1.04-1.56). Among serum electrolytes, variability in sodium and potassium measures were also significantly associated with a higher risk of primary composite events (sodium: HR per 1-SD higher ASV, 1.14; 95% CI, 1.01-1.30 and potassium: HR per 1-SD higher ASV, 1.21; 95% CI, 1.02-1.44). Conclusions and Relevance In HFpEF, visit-to-visit variability in laboratory indexes of kidney function and serum electrolytes is common and independently associated with worse long-term clinical outcomes. | Notes: | Pandey, A (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Cardiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA. ambarish.pandey@utsouthwestern.edu |
Other: | Pandey, A (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Cardiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA. ambarish.pandey@utsouthwestern.edu | Keywords: | Aged;Ambulatory Care;Biological Variation, Individual;Blood Urea Nitrogen;Cardiovascular Diseases;Chlorides;Creatinine;Female;Heart Arrest;Heart Failure;Hospitalization;Humans;Kidney Function Tests;Male;Middle Aged;Potassium;Prognosis;Sodium;Stroke Volume | Document URI: | http://hdl.handle.net/1942/33067 | ISSN: | 2380-6583 | e-ISSN: | 2380-6591 | DOI: | 10.1001/jamacardio.2020.5592 | ISI #: | WOS:000592904400004 | Rights: | 2020 American Medical Association. All rights reserved. | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2021 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
jamacardiology_segar_2020_oi_200078_1610043984.1861.docx Restricted Access | Published version | 120.7 kB | Microsoft Word | View/Open Request a copy |
WEB OF SCIENCETM
Citations
19
checked on Sep 28, 2024
Page view(s)
48
checked on Jun 29, 2023
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.